<!DOCTYPE html><html><head>
      <title>藥理</title>
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width, initial-scale=1.0">
      
      <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.22/dist/katex.min.css">
      
      
      
      
      
      <style>
      pre{font-family:Menlo,Monaco,Consolas,'Courier New',monospace;direction:ltr;text-align:left;white-space:pre;word-spacing:normal;word-break:normal;padding:1em;margin:.5em 0;overflow:auto;line-height:1.5;tab-size:4;hyphens:none;color:#aab1bf;background-color:#30353f!important;border:#4b5261;border-radius:3px}pre[class*=language-]{padding:1em}code[class*=language-] .token.cdata,code[class*=language-] .token.comment,code[class*=language-] .token.doctype,code[class*=language-] .token.prolog,pre[class*=language-] .token.cdata,pre[class*=language-] .token.comment,pre[class*=language-] .token.doctype,pre[class*=language-] .token.prolog{color:#5b6270}code[class*=language-] .namespace,pre[class*=language-] .namespace{opacity:.7}code[class*=language-] .token.constant,pre[class*=language-] .token.constant{color:#d19965}code[class*=language-] .token.boolean,code[class*=language-] .token.function-name,code[class*=language-] .token.number,pre[class*=language-] .token.boolean,pre[class*=language-] .token.function-name,pre[class*=language-] .token.number{color:#d19965}code[class*=language-] .token.tag,pre[class*=language-] .token.tag{color:#df6b75}code[class*=language-] .token.symbol,pre[class*=language-] .token.symbol{color:#56b5c2}code[class*=language-] .token.selector,pre[class*=language-] .token.selector{color:#c578dd}code[class*=language-] .token.attr-name,pre[class*=language-] .token.attr-name{color:#d19965}code[class*=language-] .token.string,pre[class*=language-] .token.string{color:#97c279}code[class*=language-] .token.char,pre[class*=language-] .token.char{color:#56b5c2}code[class*=language-] .token.url,pre[class*=language-] .token.url{color:#56b5c2}code[class*=language-] .token.operator,pre[class*=language-] .token.operator{color:#aab1bf}code[class*=language-] .token.atrule,code[class*=language-] .token.attr-value,code[class*=language-] .token.keyword,pre[class*=language-] .token.atrule,pre[class*=language-] .token.attr-value,pre[class*=language-] .token.keyword{color:#c578dd}code[class*=language-] .token.function,pre[class*=language-] .token.function{color:#61afef}code[class*=language-] .token.class-name,pre[class*=language-] .token.class-name{color:#e4bf7a}code[class*=language-] .token.variable,pre[class*=language-] .token.variable{color:#d19965}code[class*=language-] .token.regex,pre[class*=language-] .token.regex{color:#56b5c2}code[class*=language-] .token.important,pre[class*=language-] .token.important{color:#df6b75}code[class*=language-] .token.bold,code[class*=language-] .token.important,pre[class*=language-] .token.bold,pre[class*=language-] .token.important{font-weight:700}code[class*=language-] .token.italic,pre[class*=language-] .token.italic{font-style:italic}code[class*=language-] .token.entity,pre[class*=language-] .token.entity{cursor:help}pre[data-line]{position:relative;padding:1em 0 1em 3em}pre[data-line] .line-highlight-wrapper{position:absolute;top:0;left:0;background-color:transparent;display:block;width:100%}pre[data-line] .line-highlight{position:absolute;left:0;right:0;padding:inherit 0;margin-top:1em;background:hsla(24,20%,50%,.08);background:linear-gradient(to right,hsla(24,20%,50%,.1) 70%,hsla(24,20%,50%,0));pointer-events:none;line-height:inherit;white-space:pre}pre[data-line] .line-highlight:before,pre[data-line] .line-highlight[data-end]:after{content:attr(data-start);position:absolute;top:.4em;left:.6em;min-width:1em;padding:0 .5em;background-color:hsla(24,20%,50%,.4);color:#f4f1ef;font:bold 65%/1.5 sans-serif;text-align:center;vertical-align:.3em;border-radius:999px;text-shadow:none;box-shadow:0 1px #fff}pre[data-line] .line-highlight[data-end]:after{content:attr(data-end);top:auto;bottom:.4em}html body{font-family:'Helvetica Neue',Helvetica,'Segoe UI',Arial,freesans,sans-serif;font-size:16px;line-height:1.6;color:#aab1bf;background-color:#272b33;overflow:initial;box-sizing:border-box;word-wrap:break-word}html body>:first-child{margin-top:0}html body h1,html body h2,html body h3,html body h4,html body h5,html body h6{line-height:1.2;margin-top:1em;margin-bottom:16px;color:#fff}html body h1{font-size:2.25em;font-weight:300;padding-bottom:.3em}html body h2{font-size:1.75em;font-weight:400;padding-bottom:.3em}html body h3{font-size:1.5em;font-weight:500}html body h4{font-size:1.25em;font-weight:600}html body h5{font-size:1.1em;font-weight:600}html body h6{font-size:1em;font-weight:600}html body h1,html body h2,html body h3,html body h4,html body h5{font-weight:600}html body h5{font-size:1em}html body h6{color:#7c869c}html body strong{color:#fff}html body del{color:#7c869c}html body a:not([href]){color:inherit;text-decoration:none}html body a{color:#56b6c2;text-decoration:none}html body a:hover{color:#74c3cd;text-decoration:none}html body img{max-width:100%}html body>p{margin-top:0;margin-bottom:16px;word-wrap:break-word}html body>ol,html body>ul{margin-bottom:16px}html body ol,html body ul{padding-left:2em}html body ol.no-list,html body ul.no-list{padding:0;list-style-type:none}html body ol ol,html body ol ul,html body ul ol,html body ul ul{margin-top:0;margin-bottom:0}html body li{margin-bottom:0}html body li.task-list-item{list-style:none}html body li>p{margin-top:0;margin-bottom:0}html body .task-list-item-checkbox{margin:0 .2em .25em -1.8em;vertical-align:middle}html body .task-list-item-checkbox:hover{cursor:pointer}html body blockquote{margin:16px 0;font-size:inherit;padding:0 15px;color:#7c869c;background-color:#393f4a;border-left:4px solid #4b5261}html body blockquote>:first-child{margin-top:0}html body blockquote>:last-child{margin-bottom:0}html body hr{height:4px;margin:32px 0;background-color:#4b5261;border:0 none}html body table{margin:10px 0 15px 0;border-collapse:collapse;border-spacing:0;display:block;width:100%;overflow:auto;word-break:normal;word-break:keep-all}html body table th{font-weight:700;color:#fff}html body table td,html body table th{border:1px solid #4b5261;padding:6px 13px}html body dl{padding:0}html body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:700}html body dl dd{padding:0 16px;margin-bottom:16px}html body code{font-family:Menlo,Monaco,Consolas,'Courier New',monospace;font-size:.85em;color:#fff;background-color:#393f4a;border-radius:3px;padding:.2em 0}html body code::after,html body code::before{letter-spacing:-.2em;content:'\00a0'}html body pre>code{padding:0;margin:0;word-break:normal;white-space:pre;background:0 0;border:0}html body .highlight{margin-bottom:16px}html body .highlight pre,html body pre{padding:1em;overflow:auto;line-height:1.45;border:#4b5261;border-radius:3px}html body .highlight pre{margin-bottom:0;word-break:normal}html body pre code,html body pre tt{display:inline;max-width:initial;padding:0;margin:0;overflow:initial;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}html body pre code:after,html body pre code:before,html body pre tt:after,html body pre tt:before{content:normal}html body blockquote,html body dl,html body ol,html body p,html body pre,html body ul{margin-top:0;margin-bottom:16px}html body kbd{color:#fff;border:1px solid #4b5261;border-bottom:2px solid #3e4450;padding:2px 4px;background-color:#393f4a;border-radius:3px}@media print{html body{background-color:#272b33}html body h1,html body h2,html body h3,html body h4,html body h5,html body h6{color:#fff;page-break-after:avoid}html body blockquote{color:#7c869c}html body pre{page-break-inside:avoid}html body table{display:table}html body img{display:block;max-width:100%;max-height:100%}html body code,html body pre{word-wrap:break-word;white-space:pre}}.markdown-preview{width:100%;height:100%;box-sizing:border-box}.markdown-preview ul{list-style:disc}.markdown-preview ul ul{list-style:circle}.markdown-preview ul ul ul{list-style:square}.markdown-preview ol{list-style:decimal}.markdown-preview ol ol,.markdown-preview ul ol{list-style-type:lower-roman}.markdown-preview ol ol ol,.markdown-preview ol ul ol,.markdown-preview ul ol ol,.markdown-preview ul ul ol{list-style-type:lower-alpha}.markdown-preview .newpage,.markdown-preview .pagebreak{page-break-before:always}.markdown-preview pre.line-numbers{position:relative;padding-left:3.8em;counter-reset:linenumber}.markdown-preview pre.line-numbers>code{position:relative}.markdown-preview pre.line-numbers .line-numbers-rows{position:absolute;pointer-events:none;top:1em;font-size:100%;left:0;width:3em;letter-spacing:-1px;border-right:1px solid #999;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}.markdown-preview pre.line-numbers .line-numbers-rows>span{pointer-events:none;display:block;counter-increment:linenumber}.markdown-preview pre.line-numbers .line-numbers-rows>span:before{content:counter(linenumber);color:#999;display:block;padding-right:.8em;text-align:right}.markdown-preview .mathjax-exps .MathJax_Display{text-align:center!important}.markdown-preview:not([data-for=preview]) .code-chunk .code-chunk-btn-group{display:none}.markdown-preview:not([data-for=preview]) .code-chunk .status{display:none}.markdown-preview:not([data-for=preview]) .code-chunk .output-div{margin-bottom:16px}.markdown-preview .md-toc{padding:0}.markdown-preview .md-toc .md-toc-link-wrapper .md-toc-link{display:inline;padding:.25rem 0}.markdown-preview .md-toc .md-toc-link-wrapper .md-toc-link div,.markdown-preview .md-toc .md-toc-link-wrapper .md-toc-link p{display:inline}.markdown-preview .md-toc .md-toc-link-wrapper.highlighted .md-toc-link{font-weight:800}.scrollbar-style::-webkit-scrollbar{width:8px}.scrollbar-style::-webkit-scrollbar-track{border-radius:10px;background-color:transparent}.scrollbar-style::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(150,150,150,.66);border:4px solid rgba(150,150,150,.66);background-clip:content-box}html body[for=html-export]:not([data-presentation-mode]){position:relative;width:100%;height:100%;top:0;left:0;margin:0;padding:0;overflow:auto}html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{position:relative;top:0;min-height:100vh}@media screen and (min-width:914px){html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{padding:2em calc(50% - 457px + 2em)}}@media screen and (max-width:914px){html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{padding:2em}}@media screen and (max-width:450px){html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{font-size:14px!important;padding:1em}}@media print{html body[for=html-export]:not([data-presentation-mode]) #sidebar-toc-btn{display:none}}html body[for=html-export]:not([data-presentation-mode]) #sidebar-toc-btn{position:fixed;bottom:8px;left:8px;font-size:28px;cursor:pointer;color:inherit;z-index:99;width:32px;text-align:center;opacity:.4}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] #sidebar-toc-btn{opacity:1}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc{position:fixed;top:0;left:0;width:300px;height:100%;padding:32px 0 48px 0;font-size:14px;box-shadow:0 0 4px rgba(150,150,150,.33);box-sizing:border-box;overflow:auto;background-color:inherit}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc::-webkit-scrollbar{width:8px}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc::-webkit-scrollbar-track{border-radius:10px;background-color:transparent}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(150,150,150,.66);border:4px solid rgba(150,150,150,.66);background-clip:content-box}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc a{text-decoration:none}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc{padding:0 16px}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper .md-toc-link{display:inline;padding:.25rem 0}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper .md-toc-link div,html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper .md-toc-link p{display:inline}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper.highlighted .md-toc-link{font-weight:800}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .markdown-preview{left:300px;width:calc(100% - 300px);padding:2em calc(50% - 457px - 300px / 2);margin:0;box-sizing:border-box}@media screen and (max-width:1274px){html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .markdown-preview{padding:2em}}@media screen and (max-width:450px){html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .markdown-preview{width:100%}}html body[for=html-export]:not([data-presentation-mode]):not([html-show-sidebar-toc]) .markdown-preview{left:50%;transform:translateX(-50%)}html body[for=html-export]:not([data-presentation-mode]):not([html-show-sidebar-toc]) .md-sidebar-toc{display:none}
/* Please visit the URL below for more information: */
/*   https://shd101wyy.github.io/markdown-preview-enhanced/#/customize-css */
.markdown-preview {
  width: 100%;
  position: absolute;
  z-index: 0;
}
.markdown-preview .title {
  align-items: center;
}
.markdown-preview .title h1 {
  border-bottom: 0;
  text-align: center;
  font-size: 2.75em;
}
.markdown-preview h1 {
  padding-bottom: 0.3rem;
  border-bottom: solid #fff;
}
.markdown-preview h2 {
  font-weight: normal;
  padding-bottom: 0.3rem;
  border-bottom: 1pt solid #8b8b8b;
}
.markdown-preview h3 {
  font-weight: bold;
}
.markdown-preview h4 {
  font-style: italic;
  font-weight: normal;
  font-size: 1.2em;
}
.markdown-preview hr {
  background-color: rgba(0, 0, 0, 0);
  border-bottom: 1pt solid #8b8b8b;
}
@media screen and (max-width: 600px) {
  .table-scroll-wrapper {
    overflow-x: auto;
    -webkit-overflow-scrolling: touch;
    -ms-overflow-style: none;
    scrollbar-width: none;
  }
  .table-scroll-wrapper::-webkit-scrollbar {
    display: none;
  }
}
.markdown-preview table {
  width: 100%;
  table-layout: fixed;
  text-align: center;
  color: #fff7f0;
  border-collapse: collapse;
  display: table;
  margin-top: 1rem;
}
@media screen and (max-width: 600px) {
  .markdown-preview table {
    table-layout: auto;
    display: table;
    overflow-x: auto;
    -webkit-overflow-scrolling: touch;
  }
}
.markdown-preview table thead {
  position: sticky;
  background-color: hsl(220, 13%, 8%);
  top: 0;
  z-index: 999;
}
.markdown-preview table th {
  text-align: center;
  font-weight: bold;
  color: #81b4f4;
  border: 1.5px solid #8b8b8b;
}
.markdown-preview table td {
  border: 1.5px solid #8b8b8b;
}
.markdown-preview table tr {
  border: 1.5px solid #8b8b8b;
}
.markdown-preview table td,
.markdown-preview table th {
  padding: 0;
  position: relative;
}
.markdown-preview table td ol,
.markdown-preview table th ol,
.markdown-preview table td ul,
.markdown-preview table th ul {
  list-style-position: inside;
  /* 控制項目符號的位置 */
  text-align: left;
  /* 文字對齊方式 */
}
.markdown-preview table .table-diagonal {
  background: linear-gradient(to top right, rgba(0, 0, 0, 0) 49%, #8b8b8b 49%, #8b8b8b 51%, rgba(0, 0, 0, 0) 51%);
  position: absolute;
  top: 0;
  left: 0;
  width: 100%;
  height: 100%;
}
.markdown-preview table .table-diagonal .top-left {
  position: absolute;
  top: 5%;
  left: 5%;
}
.markdown-preview table .table-diagonal .top-right {
  position: absolute;
  top: 5%;
  right: 5%;
}
.markdown-preview table .table-diagonal .bottom-right {
  position: absolute;
  bottom: 5%;
  right: 5%;
}
.markdown-preview table .table-diagonal .bottom-left {
  position: absolute;
  bottom: 5%;
  left: 5%;
}
img {
  max-width: 100%;
  width: 80%;
  top: 0.3rem;
  position: relative;
  left: 50%;
  transform: translate(-50%, 0);
  display: block;
  padding: 0;
  background-color: white;
  margin-top: 0.3rem;
  margin-bottom: 0.3rem;
}
html body[for="html-export"]:not([data-presentation-mode])[html-show-sidebar-toc] .markdown-preview,
html body[for="html-export"]:not([data-presentation-mode]):not([html-show-sidebar-toc]) .markdown-preview {
  left: 0;
  width: 100%;
  max-width: 1000px;
  box-sizing: border-box;
  margin-right: auto;
  margin-left: auto;
  padding: 2em;
  transform: translateX(0);
}
html body[for="html-export"]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc {
  position: fixed;
  top: 0;
  left: 0;
  width: 200px;
  height: 100%;
  padding: 50px 10px 48px 0;
  font-size: 14px;
  box-shadow: 0 0 4px rgba(150, 150, 150, 0.33);
  box-sizing: border-box;
  overflow: auto;
  background-color: inherit;
}
html body {
  background-color: hsl(220, 13%, 18%);
  /* === Markdown Preview Enhancer TOC 樣式新版 === */
  /* 縮排*/
  /* TOC link */
  /* 每層 details 都要重置下一層 counter */
  /* 第一層：h1 */
  /* 第二層：h2 */
  /* 第三層：h3 */
  /* 第四層：h4 */
  /* 縮排 
.md-sidebar-toc .md-toc-link-wrapper { padding-left: 0.5rem; }
.md-sidebar-toc details > div > .md-toc-link-wrapper { padding-left: 1rem; }
.md-sidebar-toc details details > div > .md-toc-link-wrapper { padding-left: 2rem; }
.md-sidebar-toc details details details > div > .md-toc-link-wrapper { padding-left: 3rem; }*/
  /* hover & active */
  /*
  /////三线表/////
  table{
      border-top: 1.5pt solid;
      border-bottom: 1.5pt solid;
      font-family:'Latin Modern Roman 10', 'LM Roman 10',"Times New Roman",Arial,"Source Han Serif SC",'simsun',sans-serif;
      text-align:center;                          //文字居中
    page-break-inside:avoid;                    //禁止断页
    width: 100%;                                //扩展表格宽度
    overflow: auto;
    margin-bottom: 8pt;                         //表格间距
    border-collapse:collapse;       
  }
  
  table .katex{
    font-size: 9pt;                             //表内公式
  }
  table td{
      font-family:'Latin Modern Roman 10', 'LM Roman 10',"Times New Roman",Arial,"Source Han Serif SC",'simsun',sans-serif;
      font-size:9pt;                              //表内文字
  }
  
  table thead{
    border-bottom: 0.75pt solid black;        //三线表中间线
  }
  
  //标题行
  table th{
      font-family:'Latin Modern Roman 10', 'LM Roman 10',"Times New Roman",Arial,"SimHei","Source Han Serif SC",'simsun',sans-serif;
      font-size:9pt;                              
  }
  */
}
html body .md-sidebar-toc {
  margin: 0;
  padding: 0.5rem 0;
  position: absolute;
  max-width: 768px;
  background-color: rgba(186, 55, 55, 0.1);
  z-index: 70;
  font-size: 0.85rem;
  line-height: 1.5;
}
html body .md-toc-link-wrapper {
  list-style: none!important;
}
html body div.md-toc-link-wrapper {
  margin-left: 0px!important;
}
html body details > div > div.md-toc-link-wrapper {
  margin-left: 24px!important;
}
html body .md-sidebar-toc a {
  color: inherit;
  text-decoration: none;
}
html body .md-sidebar-toc a:hover {
  color: #87ffff;
  font-style: italic;
}
html body .md-sidebar-toc {
  counter-reset: toc-h1;
}
html body .md-sidebar-toc details {
  counter-reset: toc-h2;
}
html body .md-sidebar-toc details details {
  counter-reset: toc-h3;
}
html body .md-sidebar-toc details details details {
  counter-reset: toc-h4;
}
html body .md-sidebar-toc > .md-toc > .md-toc-link-wrapper:before,
html body .md-sidebar-toc > .md-toc > details > summary.md-toc-link-wrapper:before {
  counter-increment: toc-h1;
  content: counter(toc-h1) ". ";
  font-size: 0.75em;
}
html body .md-sidebar-toc details > div > .md-toc-link-wrapper:before,
html body .md-sidebar-toc details > div > details > summary.md-toc-link-wrapper:before {
  counter-increment: toc-h2;
  content: counter(toc-h1) "." counter(toc-h2) " ";
  font-size: 0.75em;
}
html body .md-sidebar-toc details details > div > .md-toc-link-wrapper:before {
  counter-increment: toc-h3;
  content: counter(toc-h1) "." counter(toc-h2) "." counter(toc-h3) " ";
  font-size: 0.75em;
}
html body .md-sidebar-toc details details details > div > .md-toc-link-wrapper:before {
  counter-increment: toc-h4;
  content: counter(toc-h1) "." counter(toc-h2) "." counter(toc-h3) "." counter(toc-h4) " ";
  font-size: 0.75em;
}
html body .md-sidebar-toc .md-toc-link-wrapper:hover {
  color: #87ffff;
  font-style: italic;
}
html body .md-sidebar-toc .md-toc-link-wrapper.active a {
  color: #87ffff;
  font-weight: bold;
}
html body .dcl {
  /* block 水平置中的方法 */
  margin: 0 auto;
  background: rgba(0, 0, 0, 0);
  overflow: hidden;
  margin-right: -1%;
}
html body header,
html body section,
html body aside,
html body .in,
html body footer {
  margin: 0 1% 0.3em 0;
}
html body section {
  float: left;
  width: 49%;
}
html body footer {
  margin-bottom: 0;
  /* 不准其他元素出現在其左右 */
  clear: both;
}
html body .btn {
  position: fixed;
  z-index: 99;
  font-size: 24px;
  color: inherit;
  text-align: center;
  width: 32px;
  cursor: pointer;
  opacity: 0.4;
  word-wrap: break-word;
}
html body .btn:active {
  opacity: 0.8;
}
@media screen and (max-width: 400px) {
  html body img {
    width: 100% !important;
  }
}
html body .fbox {
  display: inline-flex;
  flex-direction: row;
  justify-content: space-between;
  flex-wrap: wrap;
  width: 90%;
  position: relative;
  left: 50%;
  transform: translateX(-50%);
}
html body .fbox img {
  position: relative;
  left: 0;
  transform: translate(0, 0);
  padding: 0;
  background-color: rgba(0, 0, 0, 0) !important;
  object-fit: contain;
}
html body table .fbox {
  left: 0;
  transform: translateX(0);
}
.modal {
  display: none;
  position: fixed;
  z-index: 1000;
  padding-top: 0;
  left: 0px;
  top: 0px;
  width: 100%;
  height: 100%;
  background-color: rgba(0, 0, 0, 0.8);
  word-wrap: break-word;
}
/* Enlarged image inside modal */
.modal-content {
  display: block;
  margin: 20px;
  max-width: 90%;
  max-height: 80vh;
  animation: zoomIn 0.3s;
  position: fixed;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%) scale(1);
  /* 初始從小尺寸開始 */
  object-fit: contain;
  background-color: rgba(0, 0, 0, 0);
}
/* Zoom in effect */
@keyframes zoomIn {
  from {
    opacity: 0;
  }
  to {
    opacity: 1;
  }
}
/* Close button (X) */
.close {
  position: absolute;
  top: 20px;
  right: 35px;
  color: white;
  font-size: 40px;
  font-weight: bold;
  cursor: pointer;
  transition: 0.3s;
}
.close:hover,
.close:focus {
  color: #bbb;
}

      </style>
      <!-- The content below will be included at the end of the <head> element. --><script type="text/javascript">
  document.addEventListener("DOMContentLoaded", function () {
    // your code here
  });
</script></head><body for="html-export">
    
    
      <div class="crossnote markdown-preview  ">
      <script src="https://kit.fontawesome.com/849ddf9236.js" crossorigin="anonymous"></script>
      <script src="../Hyper_md/jquery-3.4.1.min.js"></script>
<link rel="stylesheet" href="../Hyper_md/md.css">
<h1 id="腎上腺素">腎上腺素 </h1>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th>種類</th>
<th>位置</th>
<th>G protein</th>
<th>effect</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="5">α1 (＋)</td>
<td><mark>升血壓</mark>: 收縮小動脈平滑肌</td>
<td rowspan="5">Gq</td>
<td rowspan="5">IP3、DAG↑ → Ca<sup>2+</sup>↑</td>
</tr>
<tr>

<td><mark>升血糖</mark>：胰島素↓, 肝臟糖解</td>


</tr>
<tr>

<td>散瞳: 收縮虹膜放射肌</td>


</tr>
<tr>

<td>收縮胃腸道括約肌、膀胱平滑肌(憋尿)、毛囊平滑肌</td>


</tr>
<tr>

<td>減少鼻黏液</td>


</tr>
<tr>
<td rowspan="7">α2 (-)</td>
<td>突觸前：NE釋放↓ → 交感↓ → <mark>降血壓</mark></td>
<td rowspan="7">Gi</td>
<td rowspan="7">adenyl cyclase↓ → cAMP↓</td>
</tr>
<tr>

<td>突觸後：血管收縮</td>


</tr>
<tr>

<td>中樞血管：舒張、減少交感活性</td>


</tr>
<tr>

<td>平滑肌舒張</td>


</tr>
<tr>

<td>射精(ejaculation)</td>


</tr>
<tr>

<td>抑制 lipolysis</td>


</tr>
<tr>

<td>眼內壓 ↓</td>


</tr>
<tr>
<td>β1 (+)</td>
<td>SA node↑ → 心跳、收縮力↑</td>
<td rowspan="9">Gs</td>
<td rowspan="9">adenyl cyclase↑ → cAMP↑</td>
</tr>
<tr>
<td rowspan="5">β2 (+/-)</td>
<td><mark>降血壓</mark>: 擴張血管平滑肌</td>


</tr>
<tr>

<td><mark>升血糖</mark>: 昇糖素↑</td>


</tr>
<tr>

<td>擴張<mark>支氣管平滑肌</mark>、子宮平滑肌(安胎)</td>


</tr>
<tr>

<td>收縮腸壁、胃壁平滑肌</td>


</tr>
<tr>

<td>活化心臟 Gi</td>


</tr>
<tr>
<td rowspan="2">β3 (+)</td>
<td><mark>利尿</mark>:膀胱逼尿肌(detrusor muscle)放鬆</td>


</tr>
<tr>

<td>活化lipolysis</td>


</tr>
<tr>
<td>D1 (+)</td>
<td>腎臟血管平滑肌舒張</td>


</tr>
<tr>
<td colspan="2">D2 (-)</td>

<td>Gi</td>
<td>adenyl cyclase↓ → cAMP↓</td>
</tr>
</tbody>
</table></div>
<h2 id="agonists">agonists </h2>
<blockquote>
<p>N 電子雲越厚，越偏 β2<br>
NE → Epinephrine → Isoproterenol → Terbutaline<br>
α2 N 接拉電子基<br>
<mark>?line</mark></p>
</blockquote>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th></th>
<th>受體</th>
<th colspan="2">effect</th>

</tr>
</thead>
<tbody>
<tr>
<td>Epinephrine <img src="paste_src/藥理-24.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>α, β</td>
<td rowspan="5">直接</td>
<td>口服無效</td>
</tr>
<tr>
<td>Norepinephrine (NE) <img src="paste_src/藥理-25.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>α, β1</td>

<td>增加迷走神經活性</td>
</tr>
<tr>
<td>Phenyl<strong>ephrine</strong> <img src="paste_src/藥理-19.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td rowspan="3">α1</td>

<td>散瞳劑(mydriatic)、 去鼻充血劑(decongestant)、提高血壓</td>
</tr>
<tr>
<td rowspan="2">Midodrine <img src="paste_src/藥理-26.png" alt="alt text" style=";background-color: white;padding:0"></td>


<td>姿勢性低血壓</td>
</tr>
<tr>



<td>Prodrug, <img src="paste_src/藥理-20.png" alt="alt text" style=";background-color: white;padding:0"></td>
</tr>
<tr>
<td>methyldopa <img src="paste_src/藥理-18.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td rowspan="8">α2</td>
<td>-</td>
<td>-</td>
</tr>
<tr>
<td>guanfacine</td>



</tr>
<tr>
<td>guanabenz</td>



</tr>
<tr>
<td>Clonidine <img src="paste_src/藥理-23.png" alt="alt text" style=";background-color: white;padding:0"></td>

<td rowspan="5">直接</td>
<td>高血壓、鎮定 <em style="color:grey">可樂定</em></td>
</tr>
<tr>
<td>Tizanidine <img src="paste_src/藥理-21.png" alt="alt text" style=";background-color: white;padding:0"></td>


<td>肌肉鬆弛劑</td>
</tr>
<tr>
<td>Brimonidine <img src="paste_src/藥理-22.png" alt="alt text" style=";background-color: white;padding:0"></td>


<td>青光眼</td>
</tr>
<tr>
<td>Dexmedetomidine</td>


<td>鎮定(sedative)</td>
</tr>
<tr>
<td>Oxymetazoline</td>


<td>去鼻充血劑(decongestant)</td>
</tr>
<tr>
<td>Isoproterenol <img src="paste_src/藥理-16.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>β</td>
<td rowspan="6">直接</td>
<td>降血壓藥</td>
</tr>
<tr>
<td>Terbutaline <img src="paste_src/藥理-15.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>β2</td>

<td>氣喘</td>
</tr>
<tr>
<td>Dobutamine (+)</td>
<td>β1, α1↓</td>

<td>強心劑</td>
</tr>
<tr>
<td>Dobutamine (-)</td>
<td>α1</td>


</tr>
<tr>
<td>-terol</td>
<td rowspan="2">β2</td>


</tr>
<tr>
<td>Ritodrine</td>


<td>安胎</td>
</tr>
<tr>
<td>Ephedrine (麻黃素) <img src="paste_src/藥理-17.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>β</td>
<td rowspan="2">mix</td>
<td>氣喘</td>
</tr>
<tr>
<td>Pseudoephedrine</td>
<td>?</td>

<td>去鼻充血劑(decongestant)</td>
</tr>
<tr>
<td rowspan="2" colspan="2"><strong>Amphetamine-Like:</strong> <br> Modafinil, Armodafinil, Tyramine</td>

<td colspan="2">競爭 NE 回收 (NET)</td>

</tr>
<tr>


<td colspan="2">NE 釋放↑</td>

</tr>
<tr>
<td colspan="2"><strong>Catecholamine Reuptake Inhibitor:</strong> <br> Cocaine, Atomoxetine, Reboxetine</td>

<td colspan="2">NET↓</td>

</tr>
</tbody>
</table></div>
<h2 id="antagonist">Antagonist </h2>
<blockquote>
<p>默認直接作用，搶受體<br>
<img src="paste_src/藥理-31.png" alt="alt text" style=";background-color: white;padding:0"></p>
</blockquote>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th></th>
<th>受體</th>
<th>r/ir</th>
<th>effect</th>
</tr>
</thead>
<tbody>
<tr>
<td>Phentolamine <br><img src="paste_src/藥理-30.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td rowspan="2">α</td>
<td>ir (24h)</td>
<td rowspan="2">治療 pheochromocytoma (嗜鉻細胞瘤) 造成的高血壓。 <br> 阻斷α2 receptor，造成 tachycardia(心跳過速), cardiac arrhinias (心臟驟停) <br> <em style="color:grey">有個性的糞系辦</em></td>
</tr>
<tr>
<td>Phenoxybenzamine <img src="paste_src/藥理-28.png" alt="alt text" style=";background-color: white;padding:0"></td>

<td>r (4h)</td>

</tr>
<tr>
<td>Prazosin</td>
<td rowspan="4">α1</td>
<td rowspan="2">R</td>
<td>治療慢性高血壓</td>
</tr>
<tr>
<td>Pra<mark>zosin</mark>, Terazosin, Doxazosin</td>


<td rowspan="3"><ul><li>尿道內括約肌↑ → 緩解攝護腺肥大(BPH)</li> <li>第一次用α1 blocker可能會有噁心<em style="color:grey">(osin)</em>、 <br>Orthostatic hypotension (姿勢性低血壓)、頭暈等症狀</li></ul></td>
</tr>
<tr>
<td>Indoramin</td>

<td rowspan="2">-</td>

</tr>
<tr>
<td>Urapidil <br><em style="color:grey">u rapid</em></td>



</tr>
<tr>
<td>Yohimbine <br> <em style="color:grey">yohi~</em></td>
<td>α2</td>
<td>-</td>
<td><ul><li>促NE釋放，交感↑</li><li>治療姿勢性低血壓、勃起障礙</li> </ul></td>
</tr>
<tr>
<td>Esm<mark>olol</mark></td>
<td rowspan="3">β1</td>
<td>-</td>
<td>藥效極短</td>
</tr>
<tr>
<td>Betaxolol</td>

<td colspan="2">青光眼</td>

</tr>
<tr>
<td>metoprolol</td>

<td colspan="2">-</td>

</tr>
<tr>
<td>Nadolol</td>
<td rowspan="3">β</td>
<td colspan="2">24h</td>

</tr>
<tr>
<td>Propranolol</td>

<td colspan="2">口服可用率低，可穿BBB</td>

</tr>
<tr>
<td>Timolol</td>

<td colspan="2">青光眼</td>

</tr>
<tr>
<td>Labetalol <br><em style="color:grey">來逼他</em></td>
<td rowspan="2">α, β</td>
<td colspan="2">治高血壓, Congestive Heart Failure (CHF)</td>

</tr>
<tr>
<td>Carvedilol, medroxalol, bucindolol</td>



</tr>
</tbody>
</table></div>
<h1 id="cholinergic-drugs">Cholinergic Drugs </h1>
<h2 id="效果">效果 </h2>
<ul>
<li>同時干擾正副交感，主宰的被影響
<ul>
<li>除了血管，正常都是交感主宰</li>
</ul>
</li>
</ul>
<blockquote>
<p>低劑量，非選擇 (low dose Atropine)</p>
</blockquote>
<div class="fbox"> 
<img src="paste_src/藥理-6.png" alt="alt text" style=";background-color: white;padding:0">
<img src="paste_src/藥理-7.png" alt="alt text" style=";background-color: white;padding:0">
</div>
<h2 id="機制">機制 </h2>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th>階段</th>
<th>蛋白</th>
<th>功能</th>
</tr>
</thead>
<tbody>
<tr>
<td>合成</td>
<td>CHT</td>
<td>將Choline傳輸到細胞內 (Choline和Na+的同向運輸)</td>
</tr>
<tr>
<td>儲存</td>
<td>VAT</td>
<td>將合成的ACh傳輸到突觸小泡中 (ACh和H+的反向運輸)</td>
</tr>
<tr>
<td>釋放</td>
<td>SNARE</td>
<td>介導突觸小泡與細胞膜融合釋出ACh</td>
</tr>
</tbody>
</table></div>
<h3 id="receptor">Receptor </h3>
<img src="paste_src/藥理-10.png" alt="alt text" style=";background-color: white;padding:0">
<h2 id="藥物">藥物 </h2>
<h3 id="direct-agonist">Direct agonist </h3>
<h4 id="類似物">類似物 </h4>
<ul>
<li>帶正電，過不了 BBB</li>
<li>分解快</li>
</ul>
<div class="fbox"> 
<img src="paste_src/藥理-11.png" alt="alt text" style="width:25%;background-color: white;padding:0">
<img src="paste_src/藥理-12.png" alt="alt text" style="width:73%;background-color: white;padding:0">
</div>
<h4 id="alkaloids-生物鹼類">Alkaloids (生物鹼類) </h4>
<ul>
<li>帶正電，無法穿越BBB</li>
<li>腸胃吸收差、BA(bioavailability)低。</li>
</ul>
<p>Muscarine<br>
<img src="paste_src/藥理-32.png" alt="alt text" style=";background-color: white;padding:0"><br>
Pilocarpine<br>
<img src="paste_src/藥理-33.png" alt="alt text" style=";background-color: white;padding:0"></p>
<h3 id="indirect-agonist-ache-inhibitors">Indirect agonist (AChE inhibitors) </h3>
<p><mark>ostigmine</mark><br>
<img src="paste_src/藥理-34.png" alt="alt text" style=";background-color: white;padding:0"></p>
<dl>
<dt>Simple alcohols</dt>
<dd>Reversible(可逆)、作用時間短(藥效僅5-15分鐘)</dd>
<dt>Carbamic acid esters (胺甲酸酯類)</dt>
<dd>Reversible(可逆)、作用時間介於另兩類之間(藥效0.5-6小時)</dd>
<dt>Organophosphates (有機磷)</dt>
<dd>Irreversible(不可逆)、作用時間長(藥效超過100小時)、生化武器</dd>
</dl>
<h1 id="local-anesthetics">Local Anesthetics </h1>
<ul>
<li>沒有選擇性</li>
<li>阻斷鈉離子通道(voltage-gated sodium ion channel)以終止痛覺傳遞</li>
<li>TAC(Tetracaine+Adrenaline+Cocaine)</li>
</ul>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th></th>
<th colspan="3">effect</th>


<th>排出</th>
</tr>
</thead>
<tbody>
<tr>
<td><em><strong>Ester-linked</strong></em></td>
<td colspan="3">mins-1h</td>


<td>血漿中esterase (Pseudocholinesterase) → 腎</td>
</tr>
<tr>
<td>Procaine <img src="paste_src/藥理-36.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>快</td>
<td>短</td>
<td>浸潤</td>
<td>降低 Sulfonamide(磺胺類抗生素)的抗菌作用。</td>
</tr>
<tr>
<td>Tetracaine <img src="paste_src/藥理-35.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>慢</td>
<td>長</td>
<td>塗抹/脊椎</td>
<td>會造成血管舒張</td>
</tr>
<tr>
<td>Cocaine <img src="paste_src/藥理-38.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>快</td>
<td>中</td>
<td>all</td>
<td>強烈的血管收縮</td>
</tr>
<tr>
<td>Amide-linked</td>
<td colspan="3">1-2h</td>


<td>肝臟P450 →腎臟</td>
</tr>
<tr>
<td>Lidocane <img src="paste_src/藥理-37.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td rowspan="2">快</td>
<td rowspan="2">中</td>
<td rowspan="2">all</td>
<td>最常用的局部麻醉，Epinephrine合併使用可延長作用時間、提升藥效</td>
</tr>
<tr>
<td>Prilocaine</td>



<td>少用，不須併用血管收縮劑</td>
</tr>
<tr>
<td>Bupivacaine</td>
<td>-</td>
<td>長</td>
<td>浸潤/ 硬膜下腔/ 脊髓</td>
<td>不影響運動</td>
</tr>
<tr>
<td>Articaine <br> <img src="paste_src/藥理-39.png" alt="alt text" style=";background-color: white;padding:0"></td>
<td>快</td>
<td>短</td>
<td>浸潤</td>
<td>取代 Procaine ，牙科</td>
</tr>
</tbody>
</table></div>
<h1 id="gaba-促進">GABA 促進 </h1>
<img src="paste_src/藥理-40.png" alt="alt text" style=";background-color: white;padding:0">
<ul>
<li>
<p>Benzodiazepine(BZD)</p>
</li>
<li>
<p>Z-drug</p>
</li>
<li>
<p>BZ1 (睡眠、焦慮)</p>
<ul>
<li>Quazepam</li>
<li>Zolpidem</li>
<li>Zaleplon</li>
</ul>
</li>
<li>
<p>抗癲癇(Anticonvulsant)</p>
<ul>
<li>Diazepam</li>
<li>Midazolam</li>
<li>Lorazepam</li>
<li>Clonazepam</li>
</ul>
</li>
</ul>
<blockquote>
<p>大鐘樓空</p>
</blockquote>
<h1 id="鎮痛劑analgesics">鎮痛劑（analgesics） </h1>
<h2 id="nsaid">NSAID </h2>
<ol>
<li>肝代謝、與albumin 結合</li>
<li>抑制COX1(constitutive)：
<ul>
<li>胃酸↑ (GI effects)</li>
<li>抑制血小板</li>
<li>鈉滯留、腎功能↓：老人、體液過少者容易(Sulindac、Nabumetone 無活性腎排出，影響小)</li>
</ul>
</li>
<li>抑制COX2(inducible)：
<ul>
<li>消炎止痛 (抑制PGE2所釋放 Bradykinin &amp; Histamine)</li>
<li>促進血小板</li>
</ul>
</li>
<li>共同副作用：促進Lipooxygenase → LTC4等增加→支氣管收縮</li>
</ol>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th colspan="2"></th>

<th>cox</th>
<th>備註</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">Salicylic acid</td>
<td>Aspirin</td>
<td colspan="2">1&gt;2</td>

</tr>
<tr>

<td>Diflunisal</td>
<td colspan="2">1,2</td>

</tr>
<tr>
<td colspan="2">Ticagrelor</td>

<td colspan="2">1,2</td>

</tr>
<tr>
<td colspan="2">Celecoxib</td>

<td rowspan="3" colspan="2">2 <br><em style="color:grey">沒奈心(Me lo xi)清理(cele)一坨(eto)，挑著清</em></td>

</tr>
<tr>
<td colspan="2">Etodolac</td>



</tr>
<tr>
<td colspan="2">Meloxicam</td>



</tr>
<tr>
<td rowspan="6">Acetate</td>
<td>Diclofenac <em style="color:grey">豬哥</em></td>
<td rowspan="6">1,2</td>
<td>肝毒性</td>
</tr>
<tr>

<td>Indomethacin</td>

<td>腎毒性最大、治(關閉)PDA</td>
</tr>
<tr>

<td>Nabumetone</td>


</tr>
<tr>

<td>Sulindac</td>


</tr>
<tr>

<td>Tolmetin <em style="color:grey">痛沒停</em></td>

<td>無法治痛風</td>
</tr>
<tr>

<td>Ketorolac</td>

<td>嚴重腸胃副作用</td>
</tr>
<tr>
<td rowspan="4">Propionate <em style="color:grey">丙 → 3 → 解熱</em></td>
<td>Ibu<mark>pro</mark>fen <em style="color:grey">嬰不破費</em></td>
<td rowspan="6">1,2</td>
<td>常見。關閉早產兒 PDA</td>
</tr>
<tr>

<td>Ketoprofen</td>


</tr>
<tr>

<td>Naproxen <em style="color:grey">nap</em></td>

<td>somnolence(嗜睡 )</td>
</tr>
<tr>

<td>Oxaprozin</td>

<td rowspan="2">長效 <em style="color:grey">POX</em></td>
</tr>
<tr>
<td colspan="2">Piroxicam</td>



</tr>
<tr>
<td>非 NASID</td>
<td>Acetaminophen</td>

<td>COX 影響小，作用於CNS，長期大量使用具肝毒性。</td>
</tr>
</tbody>
</table></div>
<dl>
<dt>PDA</dt>
<dd>開放動脈導管 (patent ductus rteriosus)</dd>
</dl>
<h2 id="dmard">DMARD </h2>
<ul>
<li>Disease-modifying antirheumatic drugs
<ul>
<li>RA 藥</li>
</ul>
</li>
</ul>
<h3 id="抑制骨髓">抑制骨髓 </h3>
<ul>
<li>Azathioprine/AZA</li>
</ul>
<h3 id="csdmards">csDMARDs </h3>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th colspan="3"></th>


</tr>
</thead>
<tbody>
<tr>
<td rowspan="4">抑制B/T cell 皆抑制骨髓</td>
<td>Azathioprine</td>
<td>口服佳</td>
</tr>
<tr>

<td>Mycophenolate mofetil (MMF)</td>
<td>抑制IMP變為GMP</td>
</tr>
<tr>

<td>Cyclophosphamide</td>
<td>烷化DNA</td>
</tr>
<tr>

<td>Leflunomide, Teriflunomide</td>
<td>-</td>
</tr>
</tbody>
</table></div>
<h3 id="biologic生物製劑">biologic(生物製劑) </h3>
<ul>
<li>Cyclosporine、Tacrolimus</li>
</ul>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th>Anti</th>
<th>-</th>
<th>-</th>
</tr>
</thead>
<tbody>
<tr>
<td>T-cell-modulating biologic</td>
<td>Abatacept</td>
<td>-</td>
</tr>
<tr>
<td>B-cell cytotoxic</td>
<td>Belimumab, Rituximab(RTX)</td>
<td><em style="color:grey">RTX 若比鄰</em></td>
</tr>
<tr>
<td>TNF-α</td>
<td>Infliximab, Adalimumab, Golimumab, Etanercept, Certolizumab</td>
<td><em style="color:grey">T 應付(inf)阿達(ada) Intern (etan)舌頭(certo)夠力(goli)</em></td>
</tr>
<tr>
<td>IL-1</td>
<td>Anakinra, Canakinumab, Rilonacept</td>
<td><em style="color:grey">1 號 ana 硬拉(inra), canal, rhino (rilo) 要12歲</em></td>
</tr>
<tr>
<td>IL-6</td>
<td>Sarilumab, Tocilizumab</td>
<td><em style="color:grey">莎莉拖戲</em></td>
</tr>
<tr>
<td>IL-17</td>
<td>Secukinumab, Ixekizumab, Brodalumab</td>
<td><em style="color:grey">Broda 一起去(17,I xe ki) 洗身體(Secu)</em></td>
</tr>
</tbody>
</table></div>
<h2 id="tsdmards">tsDMARDs </h2>
<ul>
<li>targeted synthetic(標靶藥物)。</li>
</ul>
<p><em style="color:grey">靶心(Barci)JK 頭髮(Tofa)</em></p>
<ul>
<li>Tofacitinib
<ul>
<li>抑制所有的 Janus kinase/JAK family</li>
<li>適應症: 發炎性腸道疾病</li>
<li>副作用: 上呼吸道感染 、泌</li>
</ul>
</li>
<li>Barcitinib
<ul>
<li>抑制 JAK1、JAK2＞JAK3</li>
<li>適應症: RA</li>
<li>副作用:感染, Herpes virus(泡疹病毒)復發</li>
</ul>
</li>
</ul>
<h2 id="endogenous-opioid-peptide-內生鴉片">endogenous opioid peptide (內生鴉片) </h2>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th>Receptor subunit</th>
<th>最佳親和</th>
</tr>
</thead>
<tbody>
<tr>
<td>μ</td>
<td>Endorphins</td>
</tr>
<tr>
<td>δ</td>
<td>Enkephalins</td>
</tr>
<tr>
<td>κ</td>
<td>Dynorphins</td>
</tr>
</tbody>
</table></div>
<dl>
<dt>NMDA Receptor</dt>
<dd>放大器 → 鴉片類耐受性</dd>
</dl>
<ul>
<li>
<p>治療腹瀉(不易進中樞) <em style="color:grey">落魄大夫治腹瀉</em></p>
<ul>
<li>Diphenoxylate (因)</li>
<li>Difenoxin (不可用於腸侵入性細菌造成之腹瀉)</li>
<li>Loperamide</li>
</ul>
</li>
<li>
<p>替代治療</p>
<ul>
<li>鴉片類的 methadone，buprenorphine <em style="color:grey">不會懦夫，沒啥痛</em></li>
<li>非鴉片類的 clonidine <em style="color:grey">可樂定</em></li>
</ul>
</li>
</ul>
<h1 id="dm">DM </h1>
<ul>
<li>Insulin</li>
<li>Secretagogues：胰島素促泌劑，因此對第一型糖尿病沒效。
<ul>
<li>Sulfonylureas</li>
<li>Meglitinides</li>
</ul>
</li>
<li>Sensitizers：胰島素增敏劑
<ul>
<li>Biguanides：Metformin</li>
<li>Thiazolidinediones(TZD)</li>
</ul>
</li>
<li>Alpha-glucosidase inhibitors：抑制碳水化合物分解，延長血糖上升時間。</li>
<li>Incretin mimetics：新藥物，能跟腸泌素一樣具有促進Insulin分泌的功能。
<ul>
<li>Glucagon-like peptide(GLP) analogs and agonists</li>
<li>Gastric inhibitory peptide(GIP) analogs</li>
</ul>
</li>
<li>DPP-4 inhibitors：Incretin易被DPP-4分解掉，故抑制此酵素能延長作用時間。</li>
<li>Sodium-glucose cotransporter 2 inhibitors：抑制腎臟對糖類的再吸收，增加糖排出</li>
</ul>
<p><em style="color:grey">gli 在前 → 飯前吃 → 促泌</em><br>
<img src="paste_src/藥理-41.png" alt="alt text" style=";background-color: white;padding:0"></p>
<h2 id="amylin-類似物">amylin 類似物 </h2>
<ul>
<li>降血糖</li>
<li>降食慾</li>
</ul>
<img src="paste_src/藥理-42.png" alt="alt text" style=";background-color: white;padding:0">
<h2 id="insulin-preparations-胰島素製劑">Insulin Preparations 胰島素製劑 </h2>
<img src="paste_src/藥理-43.png" alt="alt text" style=";background-color: white;padding:0">
<h2 id="促泌劑">促泌劑 </h2>
<p>作用在K+ channel，使K+ channel關閉，促進胰島素分泌</p>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th colspan="2"></th>

<th>作用</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="5">Sulfonylureas <em style="color:grey">gli在前面，飯前</em></td>
<td>Tolbutamide, Chlorpropamide, Tolazamide, Acetohexamide (臨床無使用)</td>
<td>hypoglycemia</td>
</tr>
<tr>

<td>Glyburide</td>
<td rowspan="4">腎、糞排除 <em style="color:grey">sul fo</em></td>
</tr>
<tr>

<td>Glipizide</td>

</tr>
<tr>

<td>Gliclazide (臨床無使用)</td>

</tr>
<tr>

<td>Glimepiride</td>

</tr>
<tr>
<td rowspan="2">Meglitinides <em style="color:grey">gli在後面，飯後</em></td>
<td colspan="2">Repaglinide</td>

</tr>
<tr>

<td colspan="2">Nateglinide</td>

</tr>
</tbody>
</table></div>
<h2 id="增敏劑">增敏劑 </h2>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th colspan="3"></th>


</tr>
</thead>
<tbody>
<tr>
<td>Biguanides</td>
<td>Metformin <br><em style="color:grey">mate for me</em></td>
<td>乳酸中毒 (禁忌：心肝腎不佳) <br> 抑制糖質新生 <br> Type 2 DM 的第一線用藥</td>
</tr>
<tr>
<td rowspan="2">Thiazolidinediones (TZD) <br><em style="color:grey">蛤蜊太熟</em></td>
<td>Troglitazone</td>
<td rowspan="2">PPARγ→↑GLUT-4 <br> 肝毒性 <br> Pioglitazone：TG↓, HDL↑ <br> Rosiglitazone：總膽固醇↑, HDL↑, LDL↑</td>
</tr>
<tr>

<td>Rosiglitazone</td>

</tr>
</tbody>
</table></div>
<h2 id="氣喘copd藥">氣喘/COPD藥 </h2>
<ul>
<li>Corticosteroid
<ul>
<li>HAT (histone acetyltransferase) ↓</li>
<li>HDAV ↑</li>
</ul>
</li>
<li>Theophyline
<ul>
<li>IL10 release</li>
<li>HDAV ↑</li>
<li>Adenosine R ↓</li>
</ul>
</li>
</ul>
<img src="paste_src/藥理-44.png" alt="alt text" style=";background-color: white;padding:0">
<h1 id="期末">期末 </h1>
<div class="table-scroll-wrapper"><table>
<thead>
<tr>
<th colspan="3">類別</th>


</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">IA</td>
<td>Quinidine</td>
<td>延長再極化期</td>
</tr>
<tr>

<td>Procainamide</td>
<td>IA <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mover><mo stretchy="true" minsize="3.0em">⇒</mo><mpadded width="+0.6em" lspace="0.3em"><mrow><mi>P</mi><mn>450</mn></mrow></mpadded></mover></mrow><annotation encoding="application/x-tex">\xRightarrow{P450}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1493em;vertical-align:-0.03em;"></span><span class="mrel x-arrow"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:1.1193em;"><span style="top:-3.341em;"><span class="pstrut" style="height:2.7em;"></span><span class="sizing reset-size6 size3 mtight x-arrow-pad"><span class="mord mtight"><span class="mord mathnormal mtight" style="margin-right:0.13889em;">P</span><span class="mord mtight">450</span></span></span></span><span class="svg-align" style="top:-2.67em;"><span class="pstrut" style="height:2.7em;"></span><span class="hide-tail" style="height:0.56em;min-width:1.526em;"><svg xmlns="http://www.w3.org/2000/svg" width="400em" height="0.56em" viewBox="0 0 400000 560" preserveAspectRatio="xMaxYMin slice"><path d="M399738 392l
-10 10c-34 36-62.7 77-86 123-3.3 8-5 13.3-5 16 0 5.3 6.7 8 20 8 7.3 0 12.2-.5
 14.5-1.5 2.3-1 4.8-4.5 7.5-10.5 49.3-97.3 121.7-169.3 217-216 28-14 57.3-25 88
-33 6.7-2 11-3.8 13-5.5 2-1.7 3-4.2 3-7.5s-1-5.8-3-7.5c-2-1.7-6.3-3.5-13-5.5-68
-17.3-128.2-47.8-180.5-91.5-52.3-43.7-93.8-96.2-124.5-157.5-9.3-8-15.3-12.3-18
-13h-6c-12 .7-18 4-18 10 0 2 1.7 7 5 15 23.3 46 52 87 86 123l10 10H0v40h399782
c-328 0 0 0 0 0l10 8c26.7 20 65.7 43 117 69-2.7 2-6 3.7-10 5-36.7 16-72.3 37.3
-107 64l-10 8H0v40zM0 157v40h399730v-40zm0 194v40h399730v-40z"></path></svg></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height:0.03em;"><span></span></span></span></span></span></span></span></span> III <br> Ach agonist</td>
</tr>
<tr>
<td>IB</td>
<td>Lidocaine, Mexiletine, Phenytoin</td>
<td>縮短再極化期, 毛地黃解毒劑,治療 TdP</td>
</tr>
<tr>
<td>IC</td>
<td>-</td>
<td>CNS effect</td>
</tr>
<tr>
<td>II</td>
<td>-olol</td>
<td>β1 blocker</td>
</tr>
<tr>
<td>III</td>
<td>Sotalol, Ibutilide, Dofetilide</td>
<td>造成TdP</td>
</tr>
<tr>
<td>I-IV</td>
<td colspan="2">Amiodarone</td>

</tr>
</tbody>
</table></div>
<ul>
<li>
<p>腎毒</p>
<ul>
<li>Cisplatin</li>
<li>Methotrexate</li>
<li>Cephalosporins</li>
<li>FQs
<ul>
<li>moxifloxacin 例外</li>
</ul>
</li>
<li>Glycopeptides
<ul>
<li>Viomycin</li>
<li>Teicoplanin</li>
<li>Bacitracin</li>
<li>Capreomycin</li>
</ul>
</li>
<li>aminoglycosides
<ul>
<li>Streptomycin</li>
<li>Gentamicin</li>
</ul>
</li>
<li>Rifamycins</li>
<li>Amphotericin B</li>
<li>Allylamines</li>
<li>Fluconazole</li>
<li>Cidofovir</li>
<li>Foscarnet</li>
</ul>
</li>
<li>
<p>骨髓抑制</p>
<ul>
<li>ganciclovir</li>
<li>valgamciclovir</li>
<li>Methotrexate</li>
<li>Chloramphenicol</li>
</ul>
</li>
<li>
<p>digitalis</p>
<ul>
<li>效果:鈉鉀幫補↓→鈉鈣幫浦排鈉留鈣 → 強心</li>
<li>風險:低血鉀(細胞鉀不足)、低血鎂(Ca<sup>2+</sup> 湧入)、細胞外高血鈣</li>
<li>副作用: 心搏過速、顫動型心律不整(即Tdp)</li>
<li>解毒: atropine, IB, AB</li>
<li></li>
</ul>
</li>
<li>
<p>鼻炎預防</p>
<ul>
<li>Corticosteroids</li>
<li>Cromolyn</li>
</ul>
</li>
<li>
<p>Anti-leukotrienes</p>
<ul>
<li>Zileuton</li>
<li>Zileuton</li>
</ul>
</li>
</ul>
<hr>
<ul>
<li>
<p>RAAS Inhibitor</p>
<ul>
<li>Direct renin inhibitor(DRI)
<ul>
<li>Aliskiren</li>
</ul>
</li>
<li>ACEI
<ul>
<li>enalapril</li>
<li>lisinopril</li>
</ul>
</li>
<li>Angiotensin II-receptor blocker(ARB)
<ul>
<li>Side: Fetotoxic</li>
<li>Valsartan</li>
</ul>
</li>
<li>aldosterone</li>
</ul>
</li>
<li>
<p>Calcium-channel blockers(CCBs)</p>
</li>
</ul>
<hr>
<p>Lipid-lowering</p>
<ul>
<li>statin
<ul>
<li>HMG-CoA Reductase inhibitor</li>
<li>CEPT inhibitor → 升 HDL</li>
<li>降 LDL</li>
<li>長效: Atorvastatin, Rosuvastatin</li>
<li>DM: Pitavastatin</li>
</ul>
</li>
<li>Ezetimib
<ul>
<li>NPC1L1 inhibitor</li>
<li>抑制小腸對於dietary和biliary cholesterol的再吸收</li>
</ul>
</li>
<li>fibrates
<ul>
<li>PPARs-α</li>
<li>增加 ApoA-Ⅰ, Ⅱ → HDL</li>
<li>形成膽結石(gallstones)</li>
</ul>
</li>
<li>Niacin
<ul>
<li>apoA-I</li>
</ul>
</li>
</ul>
<img src="paste_src/藥理-45.png" alt="alt text" style=";background-color: white;padding:0">
<p>內碼<br>
1176565573</p>
<br><br>

<script type="text/javascript" src="../Hyper_md/md.js"></script>

<script>
var page = document.getElementsByClassName('markdown-preview')[0]
page.addEventListener('click', function(event) {
  event.stopPropagation()
  
  document.body.removeAttribute('html-show-sidebar-toc');
 
})
</script>


      </div>
      <div class="md-sidebar-toc">
<div class="md-toc">
<details style="padding:0;;padding-left:0px;" open="">
        <summary class="md-toc-link-wrapper">
          <a href="#腎上腺素" class="md-toc-link"><p>腎上腺素</p>
</a>
          </summary>
        <div>
          <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#agonists" class="md-toc-link">
            <p>agonists</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#antagonist" class="md-toc-link">
            <p>Antagonist</p>

          </a></div>
        </div>
      </details>
    <details style="padding:0;;padding-left:0px;" open="">
        <summary class="md-toc-link-wrapper">
          <a href="#cholinergic-drugs" class="md-toc-link"><p>Cholinergic Drugs</p>
</a>
          </summary>
        <div>
          <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#效果" class="md-toc-link">
            <p>效果</p>

          </a></div><details style="padding:0;;padding-left:24px;" open="">
        <summary class="md-toc-link-wrapper">
          <a href="#機制" class="md-toc-link"><p>機制</p>
</a>
          </summary>
        <div>
          <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#receptor" class="md-toc-link">
            <p>Receptor</p>

          </a></div>
        </div>
      </details>
    <details style="padding:0;;padding-left:24px;" open="">
        <summary class="md-toc-link-wrapper">
          <a href="#藥物" class="md-toc-link"><p>藥物</p>
</a>
          </summary>
        <div>
          <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#direct-agonist" class="md-toc-link">
            <p>Direct agonist</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#indirect-agonist-ache-inhibitors" class="md-toc-link">
            <p>Indirect agonist (AChE inhibitors)</p>

          </a></div>
        </div>
      </details>
    
        </div>
      </details>
    <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:18px">
          <a href="#local-anesthetics" class="md-toc-link">
            <p>Local Anesthetics</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:18px">
          <a href="#gaba-促進" class="md-toc-link">
            <p>GABA 促進</p>

          </a></div><details style="padding:0;;padding-left:0px;" open="">
        <summary class="md-toc-link-wrapper">
          <a href="#鎮痛劑analgesics" class="md-toc-link"><p>鎮痛劑（analgesics）</p>
</a>
          </summary>
        <div>
          <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#nsaid" class="md-toc-link">
            <p>NSAID</p>

          </a></div><details style="padding:0;;padding-left:24px;" open="">
        <summary class="md-toc-link-wrapper">
          <a href="#dmard" class="md-toc-link"><p>DMARD</p>
</a>
          </summary>
        <div>
          <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#抑制骨髓" class="md-toc-link">
            <p>抑制骨髓</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#csdmards" class="md-toc-link">
            <p>csDMARDs</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#biologic生物製劑" class="md-toc-link">
            <p>biologic(生物製劑)</p>

          </a></div>
        </div>
      </details>
    <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#tsdmards" class="md-toc-link">
            <p>tsDMARDs</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#endogenous-opioid-peptide-內生鴉片" class="md-toc-link">
            <p>endogenous opioid peptide (內生鴉片)</p>

          </a></div>
        </div>
      </details>
    <details style="padding:0;;padding-left:0px;" open="">
        <summary class="md-toc-link-wrapper">
          <a href="#dm" class="md-toc-link"><p>DM</p>
</a>
          </summary>
        <div>
          <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#amylin-類似物" class="md-toc-link">
            <p>amylin 類似物</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#insulin-preparations-胰島素製劑" class="md-toc-link">
            <p>Insulin Preparations 胰島素製劑</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#促泌劑" class="md-toc-link">
            <p>促泌劑</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#增敏劑" class="md-toc-link">
            <p>增敏劑</p>

          </a></div><div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:42px">
          <a href="#氣喘copd藥" class="md-toc-link">
            <p>氣喘/COPD藥</p>

          </a></div>
        </div>
      </details>
    <div class="md-toc-link-wrapper" style="padding:0;;display:list-item;list-style:square;margin-left:18px">
          <a href="#期末" class="md-toc-link">
            <p>期末</p>

          </a></div>
</div>
</div>
      <a id="sidebar-toc-btn">≡</a>
    
    
    
    
    
    
<script>

var sidebarTOCBtn = document.getElementById('sidebar-toc-btn')
sidebarTOCBtn.addEventListener('click', function(event) {
  event.stopPropagation()
  if (document.body.hasAttribute('html-show-sidebar-toc')) {
    document.body.removeAttribute('html-show-sidebar-toc')
  } else {
    document.body.setAttribute('html-show-sidebar-toc', true)
  }
})
</script>
      
  
    </body></html>